ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 206 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,397,480 | -92.5% | 39,200 | -90.3% | 0.00% | -91.5% |
Q2 2023 | $18,626,095 | -4.9% | 403,774 | -17.3% | 0.05% | -16.1% |
Q1 2023 | $19,583,076 | -4.4% | 488,356 | +10.5% | 0.06% | -12.5% |
Q4 2022 | $20,474,895 | +93.6% | 441,936 | +73.0% | 0.06% | +77.8% |
Q3 2022 | $10,576,000 | +213.7% | 255,389 | +352.0% | 0.04% | +227.3% |
Q2 2022 | $3,371,000 | +19.3% | 56,500 | +45.2% | 0.01% | +37.5% |
Q1 2022 | $2,825,000 | +20.9% | 38,900 | +50.2% | 0.01% | +60.0% |
Q3 2021 | $2,336,000 | -91.6% | 25,900 | -91.1% | 0.01% | -92.1% |
Q2 2021 | $27,677,000 | +68.4% | 290,264 | +101.1% | 0.06% | +46.5% |
Q1 2021 | $16,432,000 | +96.8% | 144,320 | +139.3% | 0.04% | +79.2% |
Q4 2020 | $8,349,000 | +1676.4% | 60,312 | +955.0% | 0.02% | +1100.0% |
Q3 2020 | $470,000 | -84.8% | 5,717 | -85.5% | 0.00% | -86.7% |
Q2 2020 | $3,094,000 | +831.9% | 39,554 | +409.8% | 0.02% | +1400.0% |
Q3 2019 | $332,000 | +18.1% | 7,759 | +94.0% | 0.00% | 0.0% |
Q4 2016 | $281,000 | -98.1% | 4,000 | -97.3% | 0.00% | -98.6% |
Q3 2015 | $14,457,000 | -2.8% | 150,113 | +3.3% | 0.07% | +7.2% |
Q2 2015 | $14,881,000 | +1769.5% | 145,341 | +1033.6% | 0.07% | +1625.0% |
Q1 2015 | $796,000 | – | 12,821 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 38,100 | $2,928,000 | 1.67% |
Opaleye Management Inc. | 80,000 | $6,149,000 | 1.59% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 410,000 | $31,517,000 | 1.06% |
Opus Point Partners Management, LLC | 6,311 | $485,000 | 1.05% |
SECTOR GAMMA AS | 68,015 | $5,228,000 | 0.87% |
Capital Impact Advisors, LLC | 27,074 | $2,061,000 | 0.76% |
FORTALEZA ASSET MANAGEMENT INC/ | 1,130 | $87,000 | 0.71% |
CAPITAL INTERNATIONAL LTD /CA/ | 46,957 | $3,610,000 | 0.63% |
Virtus ETF Advisers LLC | 8,794 | $676,000 | 0.60% |
Rock Springs Capital Management LP | 200,000 | $15,374,000 | 0.59% |